USFDA approves Unichem’s Atenolol and Chlorthalidone Tablets

Last Updated on October 17, 2024 by The Health Master

Unichem Laboratories has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations.

Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure.

The product will be commercialized from Unichem’s Ghaziabad Plant.

• Bulk drug import from China continues to rise in 5 years
• Stay action against Pharma units manufacturing Nutraceuticals: High Court
• NPPA fixed retail price of 7 formulations: December 2024
• Revised Schedule M: Industry seeks balance between Quality and Viability
• FDA Karnataka enters a New Era of Food and Drug Safety
• Key Notes on Revised Schedule M: Point No. 13 – Equipment

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram..